LAUNXP Biomedical Co., Ltd (TPEX:6876)
Taiwan · Delayed Price · Currency is TWD 15.20
-0.15 (-0.98%)
Oct 8, 2026, 2:18 PM CST
LAUNXP Biomedical Market Cap
LAUNXP Biomedical has a market cap or net worth of 493.31 million as of October 9, 2026. It is the 38,899th most valuable company in the world and the 2,269th biggest in Taiwan. Its market cap has decreased by 40.62% in one year.
Market Cap
493.31M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#2,269 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since January 18, 2024, LAUNXP Biomedical's market cap has decreased from 721.03M to 493.31M, a decrease of -31.58%. That is a compound annual growth rate of -13.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 493.31M | -35.04% |
| Dec 31, 2025 | 759.44M | 11.55% |
| Dec 31, 2024 | 680.79M | -5.58% |
| Jan 18, 2024 | 721.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NatureWise Biotech & Medicals | 809.22M |
| TCI GENE | 787.53M |
| BioLASCO Taiwan | 729.94M |
| Neith | 703.95M |
| Taiwan Advance Bio-Pharmaceutical | 670.50M |
| Enimmune | 660.00M |
| SynCore Biotechnology Co.,Ltd | 629.45M |
| Lukas Biomedical | 585.16M |